|
1. |
Treatment of Renal Anemia with Recombinant Human Erythropoietin |
|
American Journal of Nephrology,
Volume 9,
Issue 5,
1989,
Page 353-362
Roland M. Schaefer,
Walter H. Hörl,
Shaul G. Massry,
Preview
|
PDF (2396KB)
|
|
ISSN:0250-8095
DOI:10.1159/000167996
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
2. |
Acute Hydrothorax in Continuous Ambulatory Peritoneal Dialysis – A Collaborative Study of 161 Centers |
|
American Journal of Nephrology,
Volume 9,
Issue 5,
1989,
Page 363-367
Yasuo Nomoto,
Takao Suga,
Keiko Nakajima,
Hideto Sakai,
Gengo Osawa,
Kazuo Ota,
Yoshindo Kawaguchi,
Tadasu Sakai,
Shinji Sakai,
Masao Shibat,
Susumu Takahashi,
Preview
|
PDF (993KB)
|
|
摘要:
Follow-up studies on 3,195 patients from 161 centers in Japan undergoing continuous ambulatory peritoneal dialysis (CAPD) were performed for 1–104 months to clarify the incidence as well as the clinical features of acute hydrothorax. In these studies, 50 patients (1.6%) developed this complication. Twenty-seven (54%) were men, and 23 (46%) were women, ranging in age form 6 to 79 (average 49) years. The interval between onset of CAPD and hydrothorax ranged from 1 day to 8 years. Four had left-sided, and 2 had bilateral hydrothorax, but the majority (88%) were right-sided. Dyspnea was experienced by 37 of these 50 patients, but the remaining 13 (26%) patients were asymptomatic. Hydrothorax was fully resolved in 27 of them following a brief interruption of CAPD or the combined use of small exchange volumes in a semi-sitting position and pleurodesis with tetracycline or other agents. The remaining 23 patients (46%) were switched to hemodialysis permanently. Despite recurrence, 1 patient continued successfully on CAPD. It was concluded that acute hydrothorax is one important possible complication, although the risk may be low. Constant surveillance is necessary to detect pleural effusions in patients during CAP
ISSN:0250-8095
DOI:10.1159/000167997
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
3. |
Methylprednisolone Therapy for Acute Crescentic Rapidly Progressive Glomerulonephritis |
|
American Journal of Nephrology,
Volume 9,
Issue 5,
1989,
Page 368-375
Kline Bolton,
Benjamin C. Sturgill,
Preview
|
PDF (1638KB)
|
|
摘要:
In the last 10 years we have evaluated 63 patients with acute crescentic rapidly progressive glomerulonephritis (AC-RPGN), 46 of whom received pulse methylprednisolone (PM). The groups consisted of patients with no immune deposits, immune complexes, vasculitis, and antiglomemlar basement membrane (anti-GBM) disease. Seventy-nine percent of non-anti-GBM patients improved versus 25% of unpulsed, p < 0.005; 70% stopped dialysis (D) versus none of unpulsed, p < 0.009; creatinine decreased from 8.6 before to 2.7 mg/dl after PM, p < 0.05. Percent crescents and oligoanuria did not influence PM results, but did with conventional therapy (prednisone, cytotoxics, anticoagulants, supportive treatment). Seventeen percent of anti-GBM patients improved, none stopped D. In anti-GBM patients, serum creatinine < 6 mg/dl was associated with a favorable response to PM, p = 0.045. Twenty-one percent of responding patients lost function at 19.8 months. The long-term response for non-anti-GBM patients was 62%. Patients with low chronicity on biopsy had shorter duration of disease (p = 0.006) and 92% initial, 85% long-term improvement; those with high chronicity had an immediate 71 %, and 36% long-term response rate, p < 0.02. Thus, PM is effective and appears superior to conventional therapy in treatment of non-anti-GBM AC-RPGN.
ISSN:0250-8095
DOI:10.1159/000167998
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
4. |
Efficacy of Exercise for End-Stage Renal Disease Patients Immediately following High-Efficiency Hemodialysis: A Pilot Study |
|
American Journal of Nephrology,
Volume 9,
Issue 5,
1989,
Page 376-383
Dennis L. Ross,
Guy M. Grabeau,
Sue Smith,
Marsha Seymour,
Nancee Knierim,
Kenneth H. Pitetti,
Preview
|
PDF (1584KB)
|
|
摘要:
Nine patients receiving maintenance high-efficiency hemodialysis were studied before and after a 12-week conditioning program to determine the efficacy of exercise immediately following hemodialysis. Each patient performed a combination of bicycle ergometry on the Schwinn Air-Dyne ergometer (SAE) and treadmill walking three times a week for a total exercise time of 15–35 min per session. A low-level Bruce treadmill test and an exercise test on the SAE were administered before and after training. Hematological, serum electrolyte, and serum lipid profiles were also determined before and after training. Following training, there were improvements in exercise capacities for both treadmill walking and ergometry on the SAE. Although a significant increase in serum apolipo-protein Al was seen following exercise, no significant changes were observed for total cholesterol, low-density -lipoprotein cholesterol, high-density-lipoprotein cholesterol or apolipoprotein B. Additionally, no significant changes were seen in hematological parameters and serum electrolyte profiles following the exercise program. The 9 patients demonstrated an average compliance record of 74%. This study demonstrated that patients on high-efficiency hemodialysis can safely engage in an exercise program immediately following dialysis at intensities and frequencies that can improve their physical work capacitie
ISSN:0250-8095
DOI:10.1159/000167999
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
5. |
Plasma DNA in Patients Undergoing Hemodialysis or Hemofiltration: Cytolysis in Artificial Kidney Is Responsible for the Release of DNA in Circulation |
|
American Journal of Nephrology,
Volume 9,
Issue 5,
1989,
Page 384-391
Gilbert J. Fournié,
Jacqueline Lulé,
Jean-Marc Dueymes,
Françoise Laval,
Irène Delobbe,
Isabelle Vernier,
Jacques P. Pourrat,
Preview
|
PDF (1611KB)
|
|
摘要:
Levels of circulating DNA increase under treatment by an artificial kidney. Using a new assay, levels of plasma DNA are studied in 45 patients during 99 sessions of hemodialysis or hemofiltration. Before the session, plasma DNA levels are increased in 41/99 samples and, among them, in 18/24 samples collected from hepatitis B surface antigen carriers. During the first 3 h of the session, plasma DNA levels increase whatever the method of treatment. At the 30th and 60th minute of hemodialysis, a positive gradient of plasma DNA exists between the output and the input of the artificial kidney. It is concluded that: (1) the increase in plasma DNA is related to the overall procedure of artificial kidney therapy; (2) death of leukocytes in the artificial kidney is responsible for the release and the increase in circulation of extracellular DNA.
ISSN:0250-8095
DOI:10.1159/000168000
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
6. |
Evolution of Ciclosporin Nephrotoxicity in Patients Treated for Autoimmune Uveitis |
|
American Journal of Nephrology,
Volume 9,
Issue 5,
1989,
Page 392-402
Howard A. Austin III,
Alan G. Palestine,
Sharda G. Sabnis,
James E. Balow,
Harry G. Preuss,
Robert B. Nussenblatt,
Tatiana T. Antonovych,
Preview
|
PDF (2251KB)
|
|
摘要:
Among 73 patients treated with ciclosporin (CS) for autoimmune uveitis, a 50% elevation of serum creatinine was observed in 37% within 3 months of starting CS and in 25% after more than 6 months of relatively uncomplicated therapy. Sequential renal function and histologic evaluations were performed in 17 patients to further characterize the nephrotoxic effects of long-term CS therapy. Inulin clearance remained essentially unchanged in 12 patients despite CS dosage reductions in the majority. In 2 such patients, repeat renal biopsy specimens revealed evidence of progressive irreversible kidney injury even though renal function was stable. Inulin clearance decreased substantially in 3 patients; in 1 case a follow-up renal biopsy showed increased severity of chronic histologic change. For 2 patients, the inulin clearance more than doubled after CS dosage reduction; and in 1 of those cases, repeat renal biopsy showed no evidence of progressive renal scarring. Overall, the morphologic attributes of irreversible kidney injury (designated by a chronicity index including glomerular sclerosis, tubular atrophy and interstitial fibrosis) were increased in 3 of 6 follow-up renal biopsy specimens. Histologic alterations of renal arterioles, including hyaline change, were observed in all CS-treated patients. The hyaline change of arterioles was either extensive in the first renal biopsy specimen or became extensive in the second biopsy in the 3 cases manifesting an increased chronicity index on the follow-up renal biopsy. Thus, parenchymal injury can progress in some cases despite CS dosage reduction and stable renal function; renal arteriolar histologic change is a prominent finding in these patients. Patients that exhibit a substantial improvement in renal function after dosage reduction may experience a more favorable course.
ISSN:0250-8095
DOI:10.1159/000168001
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
7. |
Regular Analgesic Intake and the Risk of End-Stage Renal Failure |
|
American Journal of Nephrology,
Volume 9,
Issue 5,
1989,
Page 403-412
Wolfgang Pommer,
Elisabeth Bronder,
Eberhard Greiser,
Uwe Helmert,
Hans J. Jesdinsky†,
Andreas Klimpel,
Klaus Borner,
Martin Molzahn,
Preview
|
PDF (1972KB)
|
|
摘要:
The strength of the association between regular analgesic intake (RAI) and end-stage renal failure (EF) has been insufficiently established until now. A case-control study was conducted to estimate the relative risks (RR) of EF after RAI (defined as consumption of 15 or more analgesic doses per month for a continuous period of at least 1 year) for cumulative drug intake, single-ingredient analgesics, combinations, and specific compounds. The case group included all patients with EF undergoing renal replacement therapy in the area of West Berlin (1984–1986, n = 921). Control subjects, matched to cases by sex, age, and nationality, were selected from a group of patients in outpatient clinics. Matching was possible for 517 cases. The RR of EF after RAI of any analgesic was 2.44 (95% confidence interval: 1.77–3.39) and after RAI of combination drugs 2.65 (95% confidence interval 1.91–3.67). No significant increase was found, however, after RAI of single-ingredient analgesics. The RR after RAI of combination drugs and for the most preferred analgesic ingredients (phenacetin, paracetamol, acetylsalicylic acid, phenazones, caffeine) increased with dose. Furthermore, a dose-time-related RR after RAI of the longest used preparation was found. Thus, the results clearly show an increased RR of EF after RAI related to both dose and exposure time of mixed analgesic compounds, but not for the use of only single-ingredient analg
ISSN:0250-8095
DOI:10.1159/000168002
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
8. |
Quiz of the Month, Questions |
|
American Journal of Nephrology,
Volume 9,
Issue 5,
1989,
Page 413-413
Preview
|
PDF (86KB)
|
|
ISSN:0250-8095
DOI:10.1159/000168003
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
9. |
The Activity of Rifampin and Analogs againstStaphylococcus epidermidisBiofilms in a CAPD Environment Model |
|
American Journal of Nephrology,
Volume 9,
Issue 5,
1989,
Page 414-420
Gregory Obst,
Raymonde F. Gagnon,
Anthony Harris,
John Prentis,
Geoffrey K. Richards,
Preview
|
PDF (1311KB)
|
|
摘要:
Rifampin has been noted to exhibit exceptional antimicrobial activity against Staphylococcus epidermidis biofilms as compared to commonly used antibiotics. To further explore this unique effect of rifampin, we evaluated the antimicrobial activity of three commercially available preparations of rifampin, two rifampin analogs (CGP29861 and rifapentine) and the parent compound rifamycin SV. These were tested against standardized S. epidermidis biofilms in various milieus. All six members of the rifamycin group tested demonstrated marked antimicrobial activity but with minor foci of resisters when tested in a peptone water environment. The microscopy of the exposed biofilms showed profound lysis and morphological distortion of the remaining cells. The synergistic elimination of the foci of resistance was achieved in an environment of fresh peritoneal dialysis (PD) solution or by the addition of vancomycin. Neither vancomycin nor fresh PD solution demonstrated significant antimicrobial activity when tested alone with biofilm preparations. Spent PD fluid markedly antagonized the activity of the rifamycins with the exception of the rifampin analogs, an effect primarily of pH. The synergistic effect of vancomycin with the rifamycins was not affected either by protein content or pH, leaving the antagonistic properties of spent PD fluid unexplained. The variable activity of the different members of the rifamycin group underlines the importance of structural differences in determining their interaction with bacterial biofilms. Further precision of the nature of these structural interactions is seen to have considerable potential for therapeutic advancement of catheter-associated sepsis.
ISSN:0250-8095
DOI:10.1159/000168004
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
10. |
Severe Hypernatremia with Impaired Thirst |
|
American Journal of Nephrology,
Volume 9,
Issue 5,
1989,
Page 421-434
Guido O. Perez,
James R. Oster,
Gary L. Robertson,
Preview
|
PDF (2932KB)
|
|
ISSN:0250-8095
DOI:10.1159/000168005
出版商:S. Karger AG
年代:1989
数据来源: Karger
|
|